CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
22 janv. 2021 08h40 HE
|
Celsion CORP
LAWRENCEVILLE, NJ, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional...
CV Sciences, Inc. to Participate in Alliance Global Partners Virtual Event
20 août 2020 08h00 HE
|
CV Sciences, Inc.
SAN DIEGO, Aug. 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp-derived cannabidiol (CBD) products, today...
VISLINK TECHNOLOGIES, INC. PRICES $6,000,000 PUBLIC OFFERING
12 févr. 2020 08h30 HE
|
Vislink Technologies, Inc.
NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”)(Nasdaq: VISL), today announced the pricing of an underwritten public offering with expected total...
COCRYSTAL PHARMA, INC. ANNOUNCES CLOSING OF $2.2 MILLION REGISTERED DIRECT OFFERING
03 févr. 2020 08h05 HE
|
Cocrystal Pharma, Inc.
BOTHELL, WA, Feb. 03, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral...
Vislink Technologies Closes $4,000,000 Public Offering
27 nov. 2019 16h16 HE
|
Vislink Technologies, Inc.
HACKETTSTOWN, NJ, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (NASDAQ: VISL) announced today that it has closed the previously announced public...
Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic Alternatives
07 oct. 2019 09h00 HE
|
Ritter Pharmaceuticals, Inc.
LOS ANGELES, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that...